We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$1.17B
AUM Growth
+$40.9M
Cap. Flow
+$11.5M
Cap. Flow %
0.98%
Top 10 Hldgs %
32.41%
Holding
523
New
1
Increased
59
Reduced
65
Closed
361

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.4M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$16.5M
3
SHW icon
Sherwin-Williams
SHW
+$10.5M
4
MUB icon
iShares National Muni Bond ETF
MUB
+$10.1M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.56M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$17.7M
2
AAPL icon
Apple
AAPL
+$5.65M
3
CCI icon
Crown Castle
CCI
+$5.32M
4
STT icon
State Street
STT
+$2.95M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.09M

Sector Composition

Rank Sector Weight
1 Financials 18.47%
2 Healthcare 11.09%
3 Technology 10.77%
4 Consumer Discretionary 5.93%
5 Industrials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGEN
151
Agenus
AGEN
$249M
$147K 0.01%
1,678
– –
RCG
152
RENN Fund
RCG
$20.7M
$100K 0.01%
100,000
– –
IOVA icon
153
Iovance Biotherapeutics
IOVA
$2.23B
$72K 0.01%
12,500
– –
DVN icon
154
Devon Energy
DVN
$51.9B
$43K ﹤0.01%
1,300
+1,000
+333% +$36.6K
DAKT icon
155
Daktronics
DAKT
$941M
$41K ﹤0.01%
40,989
+134
+0.3% +$1.26K
TSLA icon
156
Tesla
TSLA
$1.24T
$38K ﹤0.01%
1,680
-3,000
-64% -$66K
CATX icon
157
Perspective Therapeutics
CATX
$332M
$33K ﹤0.01%
5,482
– –
HOLX
158
DELISTED
Hologic
HOLX
$33K ﹤0.01%
32,504
– –
PTN
159
Palatin Technologies
PTN
$13.7M
$10K ﹤0.01%
20
– –
AAL icon
160
American Airlines Group
AAL
$9.58B
– –
-725
Closed -$32K
ABBV icon
161
AbbVie
ABBV
$458B
– –
-1,408
Closed -$94K
ABT icon
162
Abbott
ABT
$180B
– –
-680
Closed -$30K
ADI icon
163
Analog Devices
ADI
$181B
– –
-860
Closed -$65K
ADNT icon
164
Adient
ADNT
$1.6B
– –
-135
Closed -$9K
AGIO icon
165
Agios Pharmaceuticals
AGIO
$2.16B
– –
-1,233
Closed -$58K
AIG icon
166
American International
AIG
$41.9B
– –
-487
Closed -$30K
ALGN icon
167
Align Technology
ALGN
$12B
– –
-250
Closed -$34K
ALL icon
168
Allstate
ALL
$66.9B
– –
-350
Closed -$29K
ALNY icon
169
Alnylam Pharmaceuticals
ALNY
$36.3B
– –
-200
Closed -$11K
AMP icon
170
Ameriprise Financial
AMP
$46.8B
– –
-51
Closed -$7K
ANSS
171
DELISTED
Ansys
ANSS
– –
-1,200
Closed -$133K
APA icon
172
APA Corp
APA
$12.8B
– –
-754
Closed -$37K
ARLP icon
173
Alliance Resource Partners
ARLP
$3.18B
– –
-250
Closed -$6K
ATMP icon
174
iPath Select MLP ETN
ATMP
$647M
– –
-1,750
Closed -$41K
AVGO icon
175
Broadcom
AVGO
$1.82T
– –
-5,050
Closed -$114K
5 6
7
8 9

Similar funds

AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $5.92B AUM 23.78% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Crestwood Advisors Group's Q2 2017 Portfolio in Review

As of Q2 2017, Crestwood Advisors Group held 523 positions worth $1.17B, up 3.6% from $1.13B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Crestwood Advisors Group's Q2 2017 filing shows 1 new, 59 increased, 65 reduced and 361 closed positions. Its largest new stake was Sherwin-Williams: 94,140 shares worth $10.7M. The largest sale was CR Bard Inc., an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Crestwood Advisors Group's largest Q2 2017 buy was Sherwin-Williams: 94,140 shares worth $10.7M.
  • Crestwood Advisors Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2017, an estimated $19.4M increase.
  • Crestwood Advisors Group's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $17.7M.
  • Crestwood Advisors Group fully exited Walmart Inc in Q2 2017, selling an estimated $572K.
  • Crestwood Advisors Group's ten largest holdings make up 32% of its $1.17B portfolio in Q2 2017.
  • Crestwood Advisors Group opened 1 new position and closed 361 in Q2 2017.
  • Crestwood Advisors Group's portfolio value rose 3.6% quarter-over-quarter to $1.17B.

Based on Crestwood Advisors Group's 13F filing for Q2 2017, filed 31 Jul 2017.